BRPI0819105A2 - composição para o tratamento e prevenção de edema de pálpebra - Google Patents

composição para o tratamento e prevenção de edema de pálpebra

Info

Publication number
BRPI0819105A2
BRPI0819105A2 BRPI0819105A BRPI0819105A BRPI0819105A2 BR PI0819105 A2 BRPI0819105 A2 BR PI0819105A2 BR PI0819105 A BRPI0819105 A BR PI0819105A BR PI0819105 A BRPI0819105 A BR PI0819105A BR PI0819105 A2 BRPI0819105 A2 BR PI0819105A2
Authority
BR
Brazil
Prior art keywords
prevention
treatment
composition
eyelid edema
eyelid
Prior art date
Application number
BRPI0819105A
Other languages
English (en)
Inventor
Minno George
Jeffrey Lane Keith
Barry Abelson Mark
Jonathan Chapin Matthew
Original Assignee
Aciex Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aciex Therapeutics Inc filed Critical Aciex Therapeutics Inc
Publication of BRPI0819105A2 publication Critical patent/BRPI0819105A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI0819105A 2007-11-08 2008-11-06 composição para o tratamento e prevenção de edema de pálpebra BRPI0819105A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US751107P 2007-11-08 2007-11-08
PCT/US2008/012513 WO2009061431A2 (en) 2007-11-08 2008-11-06 Compositions for the treatment and prevention of eyelid swelling comprising an osmotically active ingredient and a vasoconstrictor

Publications (1)

Publication Number Publication Date
BRPI0819105A2 true BRPI0819105A2 (pt) 2019-09-24

Family

ID=40329067

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0819105A BRPI0819105A2 (pt) 2007-11-08 2008-11-06 composição para o tratamento e prevenção de edema de pálpebra

Country Status (8)

Country Link
EP (1) EP2219630A2 (pt)
JP (1) JP2011503061A (pt)
CN (1) CN101977595A (pt)
AU (1) AU2008325214A1 (pt)
BR (1) BRPI0819105A2 (pt)
CA (1) CA2705050A1 (pt)
MX (1) MX2010005012A (pt)
WO (1) WO2009061431A2 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120225918A1 (en) * 2011-03-03 2012-09-06 Voom, Llc Compositions and Methods for Non-Surgical Treatment of Ptosis
WO2013065720A1 (ja) * 2011-11-01 2013-05-10 ロート製薬株式会社 眼科用水性組成物
EA021247B1 (ru) * 2012-03-26 2015-05-29 Ооо "Фармацевтическая Компания "Славянская Аптека" Фармацевтический состав, обладающий сосудосуживающим, антиконгестивным, противовоспалительным действием (варианты)
EA021234B1 (ru) * 2012-03-27 2015-05-29 Ооо "Фармацевтическая Компания "Славянская Аптека" Фармацевтический состав, обладающий сосудосуживающим, антиконгестивным, противовоспалительным действием (варианты)
JP6373551B2 (ja) * 2012-05-30 2018-08-15 味の素株式会社 ガロタンニン含有組成物
AU2013201465B2 (en) 2012-10-24 2016-03-03 Rayner Surgical (Ireland) Limited Stable preservative-free mydriatic and anti-inflammatory solutions for injection
CN105188691A (zh) * 2013-05-06 2015-12-23 阿勒根公司 用于治疗组织创伤的α-肾上腺素能激动剂
TWI705812B (zh) 2014-12-01 2020-10-01 奥默羅斯公司 用於抑制術後眼睛炎性病況的抗炎和散瞳前房溶液
US9820954B2 (en) 2015-08-19 2017-11-21 Jenivision Inc. Quantitative peri-orbital application of ophthalmology drugs
WO2017132410A1 (en) * 2016-01-26 2017-08-03 Frank Litvack Compositions and uses of alpha-adrenergic agents
EP3970803A1 (en) * 2020-09-22 2022-03-23 Beiersdorf AG Cosmetic composition of low osmolality
US20240156786A1 (en) * 2021-03-03 2024-05-16 Voom, Llc Compositions and methods for treatment of blepharitis
CN117771183B (zh) * 2024-02-27 2024-05-03 深圳大佛药业股份有限公司 一种盐酸羟甲唑啉喷雾剂及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2618428A (en) * 1947-01-27 1952-11-18 John K M Harrison Shock resistant container
US5188826A (en) * 1988-02-08 1993-02-23 Insite Vision Incorporated Topical ophthalmic suspensions
IT1248014B (it) * 1991-06-07 1995-01-05 Inverni Della Beffa Spa Preparazioni oftalmiche a rilascio protratto
US5811446A (en) * 1997-04-18 1998-09-22 Cytos Pharmaceuticals Llc Prophylactic and therapeutic methods for ocular degenerative diseases and inflammations and histidine compositions therefor
US7691829B2 (en) * 1998-03-24 2010-04-06 Petito George D Composition and method for healing tissues
US6274626B1 (en) * 1998-12-22 2001-08-14 Bausch & Lomb Incorporated Pheniramine-containing compositions and method for treating allergic responses
JP2001187728A (ja) * 1999-12-28 2001-07-10 Lion Corp 眼科用組成物
DE10000612A1 (de) * 2000-01-10 2001-07-19 Min Becker Flüssigkeitspräparate für Augen- und Nasen-Tropfen bzw. Nasenspray ohne Konservierungsmittel
JP2002308775A (ja) * 2001-04-06 2002-10-23 Rohto Pharmaceut Co Ltd 外用組成物
US7288263B2 (en) * 2004-09-13 2007-10-30 Evera Laboratories, Llc Compositions and methods for treatment of skin discoloration
MX2007006233A (es) * 2004-11-24 2007-11-23 Medpointe Healthcare Inc Composiciones que comprenden azelastina y metodos de uso de la misma.
JP2006232792A (ja) * 2005-02-21 2006-09-07 Aile De Beaute:Kk 肌老化改善化粧料
EP3150209B1 (en) * 2006-03-31 2019-07-24 Vistakon Pharmaceuticals, LLC Ocular allergy treatments
CA2650592A1 (en) * 2006-04-26 2007-11-08 Aciex, Inc. Compositions for the treatment and prevention of eyelid swelling

Also Published As

Publication number Publication date
AU2008325214A1 (en) 2009-05-14
CN101977595A (zh) 2011-02-16
WO2009061431A2 (en) 2009-05-14
JP2011503061A (ja) 2011-01-27
CA2705050A1 (en) 2009-05-14
MX2010005012A (es) 2010-06-23
EP2219630A2 (en) 2010-08-25
WO2009061431A3 (en) 2009-07-23

Similar Documents

Publication Publication Date Title
BRPI0819105A2 (pt) composição para o tratamento e prevenção de edema de pálpebra
BRPI0819241A2 (pt) Compostos derivados de amina para o tratamento de distúrbios e doenças oftálmicas
CR11019A (es) 3-imidazolil-indoles para el tratamiento de enfermedades proliferativas
BRPI0916862A2 (pt) compostos úteis para o tratamento de doenças degenerativas e inflamatórias
BRPI0919920A2 (pt) compostos para tratamento de doenças e desordens oftálmicas
BRPI0921237A2 (pt) métodos e composições para o tratamento de distúrbios associados ao complemento
ES2525801T8 (es) Composiciones y métodos para la prevención y el tratamiento de enfermedades autoinmunes
BRPI0716844A2 (pt) Inidores de quinase úteis para o tratamento de doenças proliferativas
BRPI0818799A2 (pt) Composições para o tratamento da doença de parkinson
BRPI0921321A2 (pt) métodos para o tratamento de indwcções e tumores
BRPI0915282A2 (pt) agonistas mistos baseados no gip para o tratamento de distúrbios metabólicos e obesidade
BRPI0813725A2 (pt) Métodos e composições para tratamento de doenças
BRPI1015569A2 (pt) compostos úteis para o tratamento de doenças degenerativas e inflamatórias.
BRPI0917444A2 (pt) composições farmacêuticas de retenção gástrica para o tratamento e prevenção de doenas do snc
DK2474321T3 (da) Sammensætninger til behandling af collagenmedierede sygdomme
BRPI0816712A2 (pt) terapia de intervalo para o tratamento de tinnitus
BRPI0911612A2 (pt) composições e métodos para o tratamento da esclerose múltipla.
BRPI1007929A2 (pt) "métodos e composições para o tratamento de neovascularização".
BRPI0915439A2 (pt) composição tópica para o tratamento de ceratose actínica
BRPI0917440A2 (pt) composições farmacêuticas oftálmicas para o tratamento de patologias neoangiogênicas do olho
BRPI0923567A2 (pt) agentes antibactericidas novos para o tratamento de infecções gram positivas
DK2117565T3 (da) Anvendelse af chitosaner til behandlingen af negleinflammatoriske sygdomme
GB0909297D0 (en) Composition for the treatment of skin conditions
BRPI0914454A2 (pt) "composição para o tratamento do tecido epitelial"
BRPI0912890A2 (pt) composição farmacêutica para o tratamento de ejaculação precoce

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law
B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.